← Open Payments lookup

JILL HARRISON: Open Payments

NPI 1518192293 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$317 in 15 payments from 9 companies in 2025. Trend: 2023 $27 · 2024 $646 · 2025 $317

Food & beverage: $317
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$81
Otsuka America Pharmaceutical, Inc.3$63
ABBVIE INC.2$48
Teva Pharmaceuticals USA, Inc.1$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Alkermes, Inc.1$21
Collegium Pharmaceutical, Inc.1$20
Janssen Pharmaceuticals, Inc1$19
Supernus Pharmaceuticals, Inc.1$19

Products named: INGREZZA, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, AUSTEDO XR, CAPLYTA, ARISTADA, Jornay PM.

Industry payments across MA — which companies pay providers there.